Summary
FY2026 1Q consolidated revenue reached JPY 1,045.3B (+18.9% YoY) and EBITDA+S JPY 292.8B (+56.5% YoY), both setting new all-time highs. The HR Technology segment's US revenue came in at +30.0% YoY, exceeding expectations, prompting an upward revision to full-year consolidated guidance: revenue of JPY 4,230.0B (+14.4%) and EBITDA+S of JPY 1,105.0B (+39.1%). CEO Dekiba highlighted case studies where AI products delivered productivity equivalent to several full-time recruiters at large enterprises, explaining that enterprise revenue acceleration is emerging as a new growth driver alongside SMBs. At the same time, management candidly addressed the need to monitor customer satisfaction amid rapid price increases and the increasing difficulty of forecasting earnings.
Key Points (Earnings Highlights and Growth Actions)
- Business Strategy And Market Assessment
- Current full-year revenue outlook of USD 11.4B against a global HR matching TAM of USD 302B — substantial whitespace remains
- Targeting penetration into the ~USD 200B market encompassing job advertising TAM of USD 34B, recruitment automation TAM of USD 68B, and staffing/placement
- The pace of AI transformation is reducing forecast accuracy; management will provide quarterly situational updates
- Current Business Progress And Drivers
- US total job postings continued to decline at -4% YoY, yet ARPJ +35% drove revenue growth
- SMB growth was driven roughly equally by three factors: customer count increases, posted job count increases, and unit price increases (each ~one-third contribution)
- Enterprise clients began placing large orders after completing ROI validation of AI products
- HRT broad personnel cost ratio declined from ~48% to ~37% YoY, reflecting disciplined cost control
- Strategic Initiatives And Inflection Points
- Further expansion of premium pricing tiers including Indeed Premium Plus (limited test for Hosted Jobs)
- Accelerating go-to-market for AI sourcing solutions targeting large enterprises
- MMT's Car Sensor introduced a GMV-linked model this fiscal year; 1Q user actions +12.5%, revenue +15.8%
- Indeed Employer Branding Suite launched globally as an annual subscription offering
Outlook And Strategy
- Full-year consolidated revenue revised upward to JPY 4,230.0B (+14.4% YoY), EBITDA+S to JPY 1,105.0B (+39.1% YoY). EBITDA+S exceeds JPY 1T for the first time
- HRT US full-year revenue set at a record USD 6.65B (+25.1%), with annual ARPJ growth expected at +30%
- HRT segment EBITDA+S margin guided at 45.8%. AI and data center costs are rising but not at a level that would materially impact EBITDA+S
- MMT segment is pursuing a shift to GMV-linked models across multiple verticals following Car Sensor, targeting medium- to long-term revenue and profit growth
- Staffing segment incorporates resilient US demand and early signs of recovery in Europe/Australia, guiding full-year revenue of JPY 1,831.0B (+7.5%)
- Of the JPY 350.0B share buyback program, JPY 120.0B (34.3%) had been executed as of end-July
Positive Factors
- US 1Q revenue of USD 1.64B marked a quarterly all-time high, achieved despite job postings sitting -57% below FY2022 1Q levels
- Expansion of premium sponsored jobs is driving monetization evolution, with ARPJ growth leaping from +1% in FY2022 to +35%
- Large enterprises are transitioning to full-scale adoption of AI products after ROI validation, capturing replacement demand for in-house recruiter costs and external agency fees
- Europe and other regions continued strong growth on a local currency basis, with UK +34% and Canada +46%
- Built on a platform of 99M Recruit IDs and 980K corporate clients, MMT's AI-driven GMV-linked model conversion is advancing across multiple verticals
- Gross cash of JPY 908.5B (end-June), providing ample liquidity
Concerns And Risks
- The Staffing segment (Japan) received an on-site inspection from the Japan Fair Trade Commission in June; potential financial impact is not yet reflected in guidance
- US total job postings continue to decline at -4% YoY; in a macro downturn, AI-driven unit price increases may not fully offset volume declines
- Management itself has flagged customer satisfaction as a concern given the pace of unit price increases
- Rapid AI evolution is reducing earnings forecast accuracy, with guidance revision risks skewed in both directions on a quarterly basis
- HRT Japan continues to face lingering impacts from gross-to-net revenue recognition changes and unprofitable business exits/downsizing
- MMT EBITDA+S margin is expected to decline to ~31% in H2 due to investments in the GMV-linked model (sales promotions and advertising expenses)
Performance Highlights
FY2026 1Q consolidated revenue was JPY 1,045.3B (+18.9% YoY), EBITDA+S JPY 292.8B (+56.5% YoY, 28.0% margin), and net income attributable to owners of parent company JPY 202.6B (+67.5% YoY). Basic EPS was JPY 145.48 (+73.2% YoY). All metrics set new quarterly records.
Segment Performance
| Segment | Revenue | YoY | EBITDA+S | EBITDA+S Margin |
|---|---|---|---|---|
| HR Technology | JPY 455,444M | +33.2% | JPY 215,771M | 47.4% |
| Staffing | JPY 455,224M | +11.5% | JPY 28,290M | 6.2% |
| MMT | JPY 141,894M | +3.7% | JPY 51,137M | 36.0% |
- HRT US Revenue (USD): USD 1,641M (+30.0% YoY)
- US ARPJ Growth: +35% YoY
- IHL US NSA JPI: -4% YoY
- HRT Europe & Other Revenue (USD): USD 611M (+28.5% YoY)
- HRT Japan Revenue: JPY 96,300M (+6.7% YoY)
- Consolidated Basic EPS: JPY 145.48 (+73.2% YoY)
- Gross Cash (End-June): JPY 908,500M
Q&A List
- Q: US ARPJ accelerated further to +35% YoY from +25% last quarter. With comments about entering a new phase through automation of manual HR tasks, and expanding TAM — do you already have a tangible sense that the playing field is shifting and TAM is expanding? Is TAM actually broadening from the existing online job board space into recruiting automation through manual task automation, is that becoming a driver, and is the addressable wallet itself growing?A: Looking at data logs from customer conversations, especially for SMBs, the shift is significant. Previously, they would post an ad somewhere, screen replies themselves, and make calls. Now, in the extreme case, they hand the process over to our platform — AI automatically matches candidates, and if the employer keeps their calendar open, interviews are set up automatically. Many customers say it has drastically reduced the time they spend on recruiting. For mid-size to large clients with budgets of USD 1–2M, they typically want to verify ROI — comparing AI sourcing and AI screening against their in-house recruiters, or noting that they've reduced spend on external agencies. Some adopt after a one-month trial once they see the ROI. Rather than just selling a tool, we believe it's important to grow in step with customers by understanding their needs and how they're evolving.
- Q: Regarding the full-year US ARPJ outlook — you mentioned increasing difficulty in forecasting. What do you currently expect to happen from Q2 onward? Is strong enterprise client growth a key driver, and how is the current guidance constructed?A: For SMBs, it's not just unit price increases — there are three components: growth in paying customers, growth in the number of jobs those customers post, and unit price increases. Right now the mix is roughly one-third, one-third, one-third. Some customers say "this is great" and start using it for additional positions, while lapsed customers come back, new customers sign up, and prices rise. For large clients, there are cases where they adopt it as an automation tool, and cases similar to SMBs where they trial it for hard-to-fill positions. We believe that highly targeted job ads will converge with AI sourcing over the next few years — ad targeting has improved so much that it's effectively encroaching on the sourcing space. Job counts are declining while unit prices are rising significantly, and with AI penetrating at this speed and driving rapid growth — while the market is very large — it's extremely difficult to forecast with precision whether growth will be 20%, 25%, or 30%.
- Q: You mentioned the need to carefully monitor customer satisfaction amid solid unit price increases. Is this not a risk you see materializing at present, but rather, given the difficulty of forecasting nine months out during a period of strong performance, is it fair to say that considering all angles led you to land on this US ARPJ level for guidance?A: That's correct. If anything, the long-term view is actually easier to think about than the medium-term two or three quarters ahead. It's clear that the manual process of reviewing 20–30 resumes, verifying licenses, and coordinating interview schedules can't persist — it will inevitably be automated. We believe the key is to grow in step with customers by understanding their needs and how they evolve.
- Q: Regarding the healthcare client case study — Indeed was assessed as delivering productivity equivalent to several recruiters for a large enterprise. Could you elaborate on what specifically drove the dramatic productivity improvement? Was it sourcing, license verification outreach, or something else?A: Healthcare clients in particular often deal with licensed positions and maintain teams of dozens of recruiters to search resume databases and reach out to candidates. What most of them are comparing is interviews set divided by cost. They look at the combined cost of resume database search subscriptions plus recruiter labor costs versus the number of interviews set, then compare that against the number of interviews set up by the AI-automated recruiter doing outreach and scheduling. That's how clients arrive at "this is equivalent to X number of recruiters."
- Q: Is the product used in the healthcare case study a general-purpose solution? Is it something that can be sold into other industries rather than being customized for specific clients?A: We believe it is general-purpose. That said, healthcare is where supply-demand dynamics are tightest in the US, with many positions requiring specific licenses or qualifications. Whether AI screening or AI sourcing delivers greater cost efficiency depends on what percentage of applicants merit an interview. Screening is easier to deploy broadly — for example, night-shift healthcare reception or construction workers where 1,000–2,000 applicants come in — so it's more universal and scalable. Fundamentally, most clients evaluate this through the lens of how many interviews can be set up at what cost.
- Q: You've indicated that this enterprise AI segment will be Indeed's next major growth engine. What does the landscape look like in three years — with non-advertising revenue growing and the enterprise client base expanding, what scenario do you envision?A: When we built the reservation system for Hot Pepper Beauty, there was internal pushback against charging salons JPY 1,000–2,000 per month, but it succeeded. With Jalan, people said we couldn't get there unless competing travel agencies went under. Uber was told San Francisco's taxi market was only USD 500M and couldn't grow beyond that, but they blew past it in about eight months. In each case, the combination of price and ease of use expanded the market beyond expectations. More people used beauty salon and travel reservations once they became easy. From a product perspective, I believe the fastest path is to enhance both monetization and matching quality. We want to strike the right balance through various initiatives while staying in close dialogue with customers.
- Q: The healthcare case study describes automating the latter stages of the recruiting process with AI — a space previously occupied by agencies and search firms. What competitive advantages does Indeed have compared to other existing players in these AI products, and how do you plan to win in automating the overall HR process?A: There are many things we want to pursue, but integrating with various systems can create significant slowdowns. So first, we're focused on the very front end — delivering the best candidates to clients as seamlessly as possible — and continuously improving that capability, which effectively eliminates downstream processes. We believe this approach is both the most efficient and the hardest for competitors to replicate. If we can scale this, it will be very compelling.
ENVALITH, INC. ("ENVALITH") provides exclusive research coverage services to domestic and international institutional investors, as well as domestic individual investors, with the objective of contributing to the development of global and Japanese capital markets by providing information necessary for considering investments in Japanese listed companies.
- Purpose and Disclaimer Regarding Investment Decisions
This report has been prepared solely for informational purposes and does not constitute a solicitation to acquire, sell, or hold securities or any other financial products. Furthermore, this report does not constitute specific investment, financial, or tax advice. Any opinions, judgments, or recommendations contained herein are not intended to induce investment activities. Please be advised that all investment decisions must be made based on the investor's own responsibility and judgment, and ENVALITH and subject company shall not be involved in any such investment decisions.
- Information Sources, Accuracy, and Disclaimer of Warranty
This report has been prepared based on a formal request from the subject company, utilizing information provided by and interviews conducted with said company. By using this report, you are deemed to have agreed to the following: 1. Information Sources: This report is prepared on the assumption that the publicly available information and information disclosed by the subject company and provided during interviews is true and reliable. ENVALITH has not independently verified or validated the veracity of such information. 2. Accuracy: The interpretations, analyses, and hypotheses or conclusions based thereon contained in this report are independently derived by ENVALITH using its own perspectives and analytical methods based on the information mentioned in the preceding paragraph. 3. Disclaimer of Warranty: In the event that there are errors or omissions in the information disclosed by the subject company, ENVALITH and subject company shall not be held liable for any inaccuracies in this report resulting therefrom. ENVALITH and subject company make no warranties, whether express or implied, regarding the accuracy, safety, validity, completeness, or any other aspect of this report, nor regarding the past or future performance of the subject company.
- Limitation of Liability
ENVALITH and subject company shall not be liable for any costs, damages, or losses (including direct, indirect, incidental, consequential, or punitive damages) arising from the use of this report or the information obtained therefrom. Users of this report acknowledge and agree that such use is at their own risk.
- Potential Conflicts of Interest
ENVALITH may have, or may have in the future, business relationships with the subject company. Accordingly, investors should be aware that conflicts of interest may exist that could affect the objectivity of this report.
- No Obligation to Change or Update Content
The contents and opinions in this report, as well as the information upon which it is based, are current as of the date of preparation and are subject to change without notice. Please be advised that ENVALITH is under no obligation to update the contents of this report, and investors must verify the timeliness of the information on their own.
- Governing Language
This report is prepared in Japanese, English, and Chinese. In the event of any discrepancy or difference in interpretation between the language versions, the Japanese version shall be treated as the original and shall prevail.
- Copyright
All rights (including copyrights) relating to this report belong to ENVALITH. Any reproduction, redistribution, or other use of all or part of this report without the prior written permission of ENVALITH is strictly prohibited.
- Use for Other Investment Products
Except where ENVALITH has provided prior written approval, the use of this report and the trademarks or trade names of ENVALITH or the subject company in connection with the information distribution, transaction, sales promotion, or advertising of any investment products (including derivatives, structured products, investment trusts, or investment assets whose price, return, or performance is based on or linked to this report) is strictly prohibited.

